Drugs & Targets FDA grants priority review to Hyrnuo in first-line HER2-mutated NSCLC May 22, 2026Vol.52 No.20
FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applicationsCritics say policies clear the way for major tobacco companies to enter fruit-flavored vape market May 15, 2026Vol.52 No.19By Sara Willa Ernst
Regulatory News After a year-long reign over tumult at FDA, Makary heads for the exitFruit-flavored e-cigs were the final blow for the commissioner May 15, 2026Vol.52 No.19By Claire Marie Porter
Cancer Policy DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions May 15, 2026Vol.52 No.19By Sara Willa Ernst
Cancer Policy ACCC and cancer community partners issue statement on U.S. drug shortages, urge action May 15, 2026Vol.52 No.19
In Brief DOD awards $8M to five institutions to improve care for glioblastoma patients May 15, 2026Vol.52 No.19
In Brief Ovarian Cancer Research Alliance launches a global AI-powered ecosystem to accelerate gynecologic cancer research May 15, 2026Vol.52 No.19
In Brief Mount Sinai and Cancer Hope Network launch peer support program to help patients navigate treatment, survivorship, and clinical trials May 15, 2026Vol.52 No.19
